| Literature DB >> 33328388 |
Zhiwen Liu1, Chengyuan Tang1, Liyu He1, Danyi Yang1, Juan Cai1, Jiefu Zhu1, Shaoqun Shu1, Yuxue Liu1, Lijun Yin1, Guochun Chen1, Yu Liu1, Dongshan Zhang1,2, Zheng Dong1,3.
Abstract
Sepsis is the leading cause of acute kidney injury (AKI). However, the pathogenesis of septic AKI remains largely unclear. Here, we demonstrate a significant decrease of microRNA-376b (miR-376b) in renal tubular cells in mice with septic AKI. Urinary miR-376b in these mice was also dramatically decreased. Patients with sepsis with AKI also had significantly lower urinary miR-376b than patients with sepsis without AKI, supporting its diagnostic value for septic AKI. LPS treatment of renal tubular cells led to the activation of NF-κB, and inhibition of NF-κB prevented a decrease of miR-376b. ChIP assay further verified NF-κB binding to the miR-376b gene promoter upon LPS treatment. Functionally, miR-376b mimics exaggerated tubular cell death, kidney injury, and intrarenal production of inflammatory cytokines, while inhibiting miR-376b afforded protective effects in septic mice. Interestingly, miR-376b suppressed the expression of NF-κB inhibitor ζ (NFKBIZ) in both in vitro and in vivo models of septic AKI. Luciferase microRNA target reporter assay further verified NFKBIZ as a direct target of miR-376b. Collectively, these results illustrate the NF-κB/miR-376b/NFKBIZ negative feedback loop that regulates intrarenal inflammation and tubular damage in septic AKI. Moreover, urinary miR-376b is a potential biomarker for the diagnosis of AKI in patients with sepsis.Entities:
Keywords: Diagnostics; Epigenetics; NF-kappaB; Nephrology
Mesh:
Substances:
Year: 2020 PMID: 33328388 PMCID: PMC7819752 DOI: 10.1172/jci.insight.142272
Source DB: PubMed Journal: JCI Insight ISSN: 2379-3708